| Not Yet Recruiting | Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging Acute Ischemic Stroke, Tenecteplase | Phase 3 | 2026-04-01 |
| Not Yet Recruiting | Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke Acute Ischemic Stroke, Tenecteplase | — | 2026-04-01 |
| Recruiting | Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC Nasopharyngeal Carcinoma (NPC) | Phase 3 | 2026-03-05 |
| Not Yet Recruiting | A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety Soft Tissue Sarcoma (STS) | Phase 2 | 2026-02-01 |
| Not Yet Recruiting | Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML AML (Acute Myeloid Leukemia), CAR-T | EARLY_Phase 1 | 2026-01-05 |
| Not Yet Recruiting | Aerosolized Mesenchymal Stem Cell-Derived Exosomes for the Prevention and Treatment of Radiation-Induced Oral Oral Mucositis (Ulcerative) Due to Radiation | Phase 2 | 2026-01-01 |
| Not Yet Recruiting | Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer Colonic Neoplasms, Neoadjuvant Therapy, Immune Checkpoint Inhibitors | Phase 3 | 2025-10-01 |
| Recruiting | Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel Clonorchiasis | Phase 4 | 2025-07-22 |
| Not Yet Recruiting | Bioabsorbable Occluder for Outlet VSD: Safety and Aortic Valve Effects Congenital Heart Defects, VSD | — | 2025-06-30 |
| Not Yet Recruiting | A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia Transfusion Dependent Beta Thalassemia | EARLY_Phase 1 | 2024-12-31 |
| Not Yet Recruiting | Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage Ta Nasopharyngeal Carcinoma (NPC) | Phase 2 | 2024-11-01 |
| Recruiting | The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III | Phase 2 | 2024-02-22 |
| Active Not Recruiting | Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer Colonic Neoplasms, Neoadjuvant Therapy, Immune Checkpoint Inhibitors | Phase 2 | 2023-11-13 |
| Recruiting | Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy Locally Advanced Nasopharyngeal Carcinoma | N/A | 2023-06-12 |
| Recruiting | A Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemi Transfusion-dependent α-Thalassemia | Phase 1 | 2023-05-08 |
| Active Not Recruiting | CRUSTAL Study in China Coronary Artery Disease, Calcification | — | 2023-05-04 |
| Completed | Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM Type2diabetes | Phase 4 | 2023-03-01 |
| Recruiting | A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TD Transfusion Dependent Beta-Thalassemia | EARLY_Phase 1 | 2023-02-22 |
| Unknown | Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepa Hepatocellular Carcinoma Non-resectable, Portal Vein Tumor Thrombus, Immune Checkpoint Inhibitors | Phase 1 / Phase 2 | 2023-02-02 |
| Recruiting | Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cance Cervical Cancer | Phase 2 | 2022-09-01 |
| Recruiting | Edaravone in the Treatment of Optic Neuritis Optic Neuritis | N/A | 2022-01-15 |
| Unknown | PCP in Immunocompromised Population in Southern China Immunocompromised Patients, Pneumocystis Pneumonia, Diagnosis | — | 2021-05-12 |
| Not Yet Recruiting | Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2020-06-01 |
| Completed | Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Diso NMO Spectrum Disorder, Azathioprine Adverse Reaction | Phase 4 | 2020-01-01 |
| Completed | Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinic Thalassemia Major | Phase 4 | 2019-07-05 |
| Unknown | Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer Esophageal Cancer | Phase 2 | 2018-11-01 |
| Unknown | Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC Non-small Cell Lung Cancer | Phase 2 | 2018-10-01 |
| Unknown | A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma Biliary Carcinoma | Phase 2 | 2018-09-10 |
| Unknown | Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 2 | 2017-05-20 |
| Unknown | Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major Thalassemia Major | Phase 4 | 2017-04-01 |
| Terminated | Gypenosides Treatment for Optic Neuritis Optic Neuritis | Phase 2 | 2017-02-04 |
| Unknown | Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 3 | 2016-10-01 |
| Unknown | Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategie Beta Thalassemia Major | N/A | 2016-08-01 |
| Completed | Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcino Nasopharyngeal Carcinoma | Phase 2 | 2014-09-01 |